Gynecologic Cancers

Latest News

Investigators note a trend towards improved overall survival with cadonilimab plus chemotherapy with or without bevacizumab among those with cervical cancer in the phase 3 AK104-303 trial.
Cadonilimab Combo Improves PFS in Recurrent/Metastatic Cervical Cancer

November 30th 2023

Investigators note a trend towards improved overall survival with cadonilimab plus chemotherapy with or without bevacizumab among those with cervical cancer in the phase 3 AK104-303 trial.

Data from the phase 2 DESTINY-PanTumor02 trial support trastuzumab deruxtecan as a potential treatment for patients with gynecologic HER2-expressing tumors that have progressed on prior therapy.
Trastuzumab Deruxtecan Showcases Clinical Efficacy in HER2+ Gynecological Cancers

November 20th 2023

Results from the phase 3 GCIG INTERLACE trial highlight progression-free survival and overall survival improvements with induction chemotherapy plus chemoradiotherapy for patients with locally advanced cervical cancer.
Induction Chemotherapy/CRT Improves Efficacy in Advanced Cervical Cancer

November 17th 2023

Progression-free survival benefit appears consistent in patients with recurrent or metastatic cervical cancer treated with tisotumab vedotin.
Tisotumab Vedotin Elicits Meaningful OS Benefit in Advanced Cervical Cancer

November 15th 2023

Investigators report acceptable morbidity and health-related quality of life with neoadjuvant chemotherapy plus surgery and concomitant chemoradiotherapy in those with cervical cancer.
Neoadjuvant Chemo/Surgery Appears Non-Superior to CRT in Cervical Cancer

September 13th 2023

Video Series
Video Interviews
Podcasts
Pharmaceutical, gynecologic oncology, and physician perspectives shed light on potentially mitigating the ongoing carboplatin and cisplatin shortages’ effects on cancer care in the United States.
Experts from University of California, Los Angeles Health and Mayo Clinic discuss key data presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in the gynecologic and gastrointestinal cancer spaces and how they may impact patient care.
Experts from UCLA Health discuss key data presented at The Society of Gynecologic Oncology 2023 Annual Meeting on Women’s Cancer and how they may apply to clinical practice.

More News